Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) guidelines for management of dyslipidemia and cardiovascular disease risk reduction: Putting evidence in context.

Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) guidelines for management of dyslipidemia and cardiovascular disease risk reduction: Putting evidence in context. Prog Cardiovasc Dis. 2021 Sep-Oct; 68:2-6.

View in: PubMed

subject areas

Biomarkers
Cardiovascular Diseases
Cholesterol
Clinical Decision-Making
Consensus
Drug Monitoring
Dyslipidemias
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Military Medicine
Primary Prevention
Protective Factors
Risk Assessment
Secondary Prevention
Time Factors
Treatment Outcome
United States
United States Department of Defense
United States Department of Veterans Affairs